User:Mr. Ibrahem/Venetoclax

Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML). It is taken by mouth. It may be used on its own or together with other medications.

Common side effects include low white blood cells, low red blood cell, high potassium, diarrhea, nausea, respiratory infections, and tiredness. Other severe side effects may include sepsis, low potassium, tumor lysis syndrome, and bleeding. It interacts with St. John’s wort. It works by attaching to a protein called Bcl-2, blocking its activity, which results in the death of cancer cells.

Venetoclax was approved for medical use in Europe and the United States in 2016. In the United Kingdom 112 tablets of 100 mg costs the NHS about £4,800. This amount in the United States costs about 12,600 USD as of 2021.